2000
DOI: 10.1053/jinf.2000.0747
|View full text |Cite
|
Sign up to set email alerts
|

Antifungal Drug Resistance in Aspergillus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
107
0
2

Year Published

2002
2002
2019
2019

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 149 publications
(110 citation statements)
references
References 105 publications
1
107
0
2
Order By: Relevance
“…This polyene antifungal agent binds to ergosterol to form pores that cause leakage of hyphal content and eventually death of the fungus (Moore et al, 2000). An16g05910 and An16g05920 are adjacent genes, both downregulated in our experiment.…”
Section: Upregulation Of An12g09940 and An03g00580mentioning
confidence: 60%
“…This polyene antifungal agent binds to ergosterol to form pores that cause leakage of hyphal content and eventually death of the fungus (Moore et al, 2000). An16g05910 and An16g05920 are adjacent genes, both downregulated in our experiment.…”
Section: Upregulation Of An12g09940 and An03g00580mentioning
confidence: 60%
“…The mechanisms of resistance to these antifungal agents by yeast isolates are purely chromosomal as Candida species lack plasmid or other natural mechanisms capable of transferring genetic materials between strains (Odds et al, 2003). Knowledge of mechanisms of antifungal resistance has been valuable in identifying resistant isolates and using them to validate in vitro measurement systems (VandenBossche et al, 1998;White et al, 1998;Ghannoum et al, 1999;Moore et al, 2000). This paper aimed to determine the antifungal resistance of Candida species among female patients clinically diagnosed with genitourinary tract infections with special emphasis on the wellstudied National Committee for Clinical Laboratory Standards (NCCLS, 2002) methodologies.…”
Section: Introductionmentioning
confidence: 99%
“…Currently, the most commonly used drugs for the treatment of aspergillosis are amphotericin B, which binds membrane sterol and creates transmembrane channels leading to an increase in membrane permeability to monovalent cations (7), and itraconazole, which competes for oxygen at the catalytic heme site of cytochrome P450/ lanosterol 14a-demethylase, leading to an inhibition of ergosterol biosynthesis and the accumulation of 14a-methylated sterols in the fungal plasma membrane (8). However, these two drugs have major disadvantages, including the nephrotoxicity of amphotericin B and the lack of itraconazole preparations for intravenous application, limiting its use in patients with impaired bowel absorption.…”
mentioning
confidence: 99%